B7-H3 is an immune regulatory molecule whose aberrant expression in tumors is associated
with adverse outcomes. Upregulation of B7-H3 may promote tumor cell proliferation and …

Abstract B7-H3, which has been reported to be a co-regulatory ligand of the B7 family, can
suppress T cell-mediated immunity and has also been reported to be expressed in many …

Recent studies have reported that the immune-regulatory protein B7-H4 is highly expressed
in various types of cancer, but little is known concerning its roles in cervical cancer. In the …

Abstract Objective To investigate B7-H4 expression and its correlation with the number of
infiltrating T lymphocytes and cytokine production by those lymphocytes in human cervical …

Introduction: It has been previously shown that B7-H4, one of the B7 family members that
serve as negative regulators of T cell function, has altered expression levels in a variety of …

Abstract B7-H6, a newly identified B7 family member molecule, binds to its receptor on NK
cells, NKp30, and then triggers the anti-tumor NK cell cytotoxicity and leads to the cytokine …

B7-H3, a novel member of the B7 family, was previously known as a regulatory ligand
regulating T-cell-mediated immune response, and in recent years it was found to take a …

Purpose The purpose of this study was to investigate B7 homolog 3 (B7-H3) expression
patterns and define its associations with programmed cell-death ligand 1 (PD-L1) …

B7-H3 belongs to the B7 superfamily, a group of molecules that costimulate or
downmodulate T cell responses. Although it has been shown that B7-H3 can inhibit T cell …

Background And Objective The investigation concerning the B7-H1 expression in colorectal
cancer cells is at an early stage. It is unclear whether B7-H1 expression may have …